| 引用本文：赵璇, 程薇, 袁蓓蓓.北京市慢性缺血性心脏病住院患者药品使用及费用研究[J].中国卫生政策研究,2020,13(2):53-60 |
|
| 北京市慢性缺血性心脏病住院患者药品使用及费用研究 |
| 投稿时间：2019-11-13 修订日期：2020-01-10 PDF全文浏览 HTML全文浏览 |
| 赵璇1, 程薇2, 袁蓓蓓1 |
1. 北京大学中国卫生发展研究中心 北京 100191;
2. 北京中医药大学 北京 100029 |
| 摘要:目的：分析慢性缺血性心脏病住院患者特征、药品使用情况、费用分布和影响因素。方法：采用统计描述、非参数检验的方法分析患者住院费用，使用关联规则挖掘药品使用规律，构建决策树模型探索影响患者住院费用的影响因素。结果：慢性缺血性心脏病患者平均住院费用为23 619.64元，费用中位数为11 087.39元，住院费用主要以材料费为主；患者药品使用呈现一定的规律，阿司匹林肠溶片、肝素钠注射液及氯化钠注射液等药物在患者诊疗过程中频繁出现；住院天数、药品使用规律、医院级别、医保类型等是影响患者费用的主要因素。结论：加强慢性缺血性心脏病疾病干预，预防疾病年轻化趋势；利用大数据和信息手段进行诊疗行为研究，为规范诊疗行为拓宽思路；探索疾病费用分布规律及影响因素，有助于为按病种付费等支付方式改革提供依据。 |
| 关键词:慢性缺血型心脏病 药品使用 住院费用 |
|
| Study on drug use and medical expenses of inpatients with chronic ischemic heart disease in Beijing |
| ZHAO Xuan1, CHENG Wei2, YUAN Bei-bei1 |
1. China Center for Health Development Studies, Peking University, Beijing 100191, China;
2. Beijing University of Chinese Medicine, Beijing 100029, China |
| Abstract:Objective: To analyze the characteristics of inpatients with chronic ischemic heart disease, and the drug use, medical cost distribution and factors of influence amongst them. Methods: Statistical description and non-parametric tests were adopted to analyze the medical expenses of inpatients with chronic ischemic heart disease, association rules were used to determine the drug use prescriptions and a decision tree model was constructed to explore the factors influencing the patient hospitalization expenses. Results: The results showed that the average hospitalization expenses for patients with chronic ischemic heart disease was 23 619.64 RMB, and the median cost was 11087.39 RMB, whereby the cost of materials accounted for the highest proportion of expenses. There are some rules in drug use of patients, and drugs such as aspirin enteric-coated tablets, heparin sodium injection drugs such as sodium chloride injection and the likes frequently appear in the therapeutic process. Length of stay at hospital, drug use prescriptions, hospital level and type of medical insurance were found to be the main factors influencing the hospitalization expenses for patients. Conclusions: The intervention for chronic ischemic heart disease patients should be strengthened and the trend of disease should be prevented amongst younger people. Big data and information technology should be used to conduct research on diagnosis and treatment behavior, as well as broadening insight for standardizing the therapeutic processes. In addition, exploring the cost distribution and influencing factors of the disease should help provide a basis evidence for the reform of payment methods. |
| Key words:Chronic ischemic heart disease Drug use Hospitalization expenses |
| 摘要点击次数: 1767 全文下载次数: 765 |
|
|
|
|
|
